skip to search skip to navigation skip to main content

R&D Strategy

Through our commitment to drug discovery and development, Astellas has a rich and unique pipeline that is continually evolving.

Selectivity and focus

From the hundreds of different drug candidates and new technologies under our investigation in our laboratories, we identify and strictly prioritise those with greatest potential to deliver new standards of care – critical for our commitment to produce first-in-class and best-in-class therapies.

Precision medicine

We aim to develop drugs that accurately target biological processes in patients with specific disease profiles, with companion diagnostics to identify those people who will receive most benefit.

Multi-track R&D

At Astellas, R&D isn’t just about us. We proactively utilise external resources and specialist excellence at every stage of the R&D process – enabling us to deliver as many innovative new drugs as possible. In the drug discovery phase, we have collaborations with some of the world’s best academic research institutions in a number of territories. In the development phase, we partner and collaborate with public and private organisations to harness complementary capabilities to science.

NPR/17/0006/APEL  April 2018

Terms of Use  |  Privacy Policy  |  Cookies Policy Copyright © 2019 Astellas Pharma Europe Ltd